中国广西接受抗逆转录病毒治疗的HIV-1感染者耐药状况及其影响因素
该研究对广西14个城市抗逆转录病毒治疗后出现病毒学失败的HIV-1感染者进行pol基因测序和耐药突变分析,共纳入8963例,HIV-1耐药总患病率为42.43%(3808/8963),2016年至2023年从59.62%降至41.40%。年龄≥50岁、男性、汉族、较低教育水平、工人/农民/儿童职业、艾滋病、治疗前CD4 T细胞计数<200 cells/mm3、CRF01_AE和CRF55_01B亚型及拉米夫定/齐多夫定/奈韦拉平方案与耐药相关,M184V(17.38%)和K103N(22.14%)为常见突变。
要点
- 广西HIV-1感染者ART后病毒学失败者耐药总患病率为42.43%(3808/8963)。
- 2016年至2023年耐药患病率从59.62%降至41.40%。
- 常见耐药突变为M184V(17.38%)和K103N(22.14%)。
核心结论
- 广西HIV-1 ART感染者耐药影响因素复杂,需持续加强耐药监测并优化ART方案以有效减少病毒学失败。
研究设计与样本
- 收集广西14个城市ART后病毒学失败的HIV-1感染者样本和数据,进行HIV-1 pol基因测序,使用斯坦福大学HIV耐药数据库分析耐药突变,采用逻辑回归识别HIV耐药和死亡的相关危险因素。
主要发现
- 共纳入8963例具有pol序列的个体,HIV-1耐药总患病率为42.43%(3808/8963)。
- 2016年至2023年HIV-1耐药患病率从59.62%降至41.40%。
- 年龄≥50岁、男性、汉族、较低教育水平、工人/农民/儿童职业、艾滋病、治疗前CD4 T细胞计数<200 cells/mm3、CRF01_AE和CRF55_01B亚型及ART方案拉米夫定/齐多夫定/奈韦拉平与HIVDR易感性较高相关。
- 常见突变为M184V(17.38%)和K103N(22.14%)。
- M184V、S68G、M41L和G190A的患病率在汉族和壮族人群间存在差异,年龄、性别、民族、教育水平、职业、感染途径、临床分期、病毒载量、亚型、ART方案和HIVDR与死亡率显著相关。
关键数值与推荐
- HIV-1耐药总患病率为42.43%(3808/8963)。
- 2016年至2023年耐药患病率从59.62%降至41.40%。
- 常见突变M184V为17.38%,K103N为22.14%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the profiles and determinants of drug resistance in HIV-1-infected individuals undergoing ART in Guangxi. METHODS: Samples and data were collected from HIV-1-infected individuals experiencing virological failure post-ART from 14 cities in Guangxi. Sequencing of the HIV-1 pol gene was conducted, followed by analysis for drug resistance mutations using the Stanford University HIV Drug Resistance Database. Logistic regression was employed to identify potential risk factors associated with both HIV drug resistance and mortality. RESULTS: A total of 8963 individuals with pol sequences were included in this study. The overall prevalence of HIV-1 drug resistance (HIVDR) was 42.43% (3808/8963), showing a decrease from 59.62% to 41.40% from 2016 to 2023. Factors such as being aged ≥50 years, male, Han nationality, lower education levels, occupations including workers, peasants and children, AIDS, pre-treatment CD4 T cell counts <200 cells/mm3, infection with CRF01_AE and CRF55_01B subtypes, and ART regimen lamivudine/zidovudine/nevirapine were associated with higher susceptibility to HIVDR. The common mutations were M184V (17.38%) and K103N (22.14%). Additionally, the prevalence of M184V, S68G, M41L and G190A were different between the Han and Zhuang populations. Factors including age, gender, ethnicity, education level, occupation, infectious route, clinical stage, viral load, subtype, ART regimen and HIVDR showed significant associations with mortality. CONCLUSIONS: The factors contributing to drug resistance in the HIV-1 ART individuals in Guangxi appear to be notably intricate. Continuous reinforcement of drug resistance surveillance is imperative, accompanied by the optimization of ART regimens to mitigate virological failures effectively.
引用
- Pang X, He Q, Tang K, et al. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China. J Antimicrob Chemother. 2024. PMID: 38551451. doi:10.1093/jac/dkae084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。